hydroxycarbamid sandoz 100 mg filmtabletten
novartis pharma gmbh - hydroxycarbamid -
hydroxycarbamid sandoz 1000 mg filmtabletten
novartis pharma gmbh - hydroxycarbamid -
hydroxycarbamid 1a pharma 100 mg - filmtabletten
1a pharma gmbh - hydroxycarbamid -
hydroxycarbamid 1a pharma 1000 mg - filmtabletten
1a pharma gmbh - hydroxycarbamid -
hydrea 500 mg hartkapsel
bristol - hydroxycarbamid - hartkapsel - 500 mg - hydroxycarbamid 500 mg - hydroxycarbamide
hydroxyurea medac 500 mg hartkapseln
medac gesellschaft für klinische spezialpräparate mbh - hydroxycarbamid - hydroxycarbamid
syrea 500 mg kapsel
medac gesellschaft für klinische spezialpräparate m.b.h. (3083854) - hydroxycarbamid - hartkapsel - hydroxycarbamid (07416) 500 milligramm
hydrea 500 mg
medicopharm ag arzneimittel & medikal produkte (8021444) - hydroxycarbamid - hartkapsel - 500 mg - teil 1 - hartkapsel; hydroxycarbamid (07416) 500 milligramm
adakveo
novartis europharm limited - crizanlizumab - anämie, sichelzellen - other hematological agents - adakveo is indicated for the prevention of recurrent vaso occlusive crises (vocs) in sickle cell disease patients aged 16 years and older. it can be given as an add on therapy to hydroxyurea/hydroxycarbamide (hu/hc) or as monotherapy in patients for whom hu/hc is inappropriate or inadequate.
litalir 500 mg - kapseln
cheplapharm arzneimittel gmbh - hydroxycarbamid - hydroxycarbamid